Somnomed Ltd has released a press release.
Investor Presentation AGM
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Somnomed
- FY25 Guidance Upgrade and Appointment of CFO
- Rest Assure - US Food and Drug Authority (FDA) Update
- Investor Presentation
- FY24 Preliminary Report and FY25 Guidance
- Preliminary Final Report
Later from Somnomed
- AGM Chairman & co-CEO addresses
- FY25 Guidance Update and Quarterly Report
- Quarterly Appendix 4C Cash Flow Report
- FY25 Half Year Results
- United States of America tariff update
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed